Lacipil

Medicinal product

(Invented) name

Lacipil

Active substance (s)

Lacidipinas

Strength

4 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C08CA09, Lacidipine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-09

Date of renewal

Documents

3304_Lacipil 4mg_pl_deng_tab_PL_2026-04-09.docx

3304_Lacipil 4mg_pl_deng_tab_PZ_2026-04-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Vienoje tabletėje yra	1 vnt.
Lacidipinas	4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120445	106548	1106548	lizdinė plokštelė	N28		Receptinis	LT/L/26/3304/001	Netiekiama	-	-	No	-	-	Download
120446	106549	1106549	lizdinė plokštelė	N56		Receptinis	LT/L/26/3304/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-09	Registruotas